MicroRNA-218-5p affects lung adenocarcinoma progression through targeting endoplasmic reticulum oxidoreductase 1 alpha

References

• Weber M, McWilliams A, Canfell K. Prospects for cost-effective lung cancer screening using risk calculators. Transl Cancer Res. 2019;8(S2):S141–s144.
   PubMedGoogle Scholar
• Ferlay J, Colombet M, Soerjomataram I, et al. Cancer statistics for the year 2020: an overview. Int J Cancer. 2021;149(4):778–789.
   Web of Science ®Google Scholar
• Patel MI, Cheng I, Gomez SL. US lung cancer trends by histologic type. Cancer. 2015;121:1150–1152.
   PubMed Web of Science ®Google Scholar
• Peters S, Adjei AA, Gridelli C, et al. Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2012;23(Suppl 7):vii56–64.
   PubMed Web of Science ®Google Scholar
• Hirsch FR, Scagliotti GV, Mulshine JL, et al. Lung cancer: current therapies and new targeted treatments. Lancet. 2017;389:299–311.
   PubMed Web of Science ®Google Scholar
• Blandin Knight S, Crosbie PA, Balata H, et al. Progress and prospects of early detection in lung cancer. Open Biol. 2017;7(9):170070.
   PubMed Web of Science ®Google Scholar
• Saliminejad K, Khorram Khorshid HR, Soleymani Fard S, et al. An overview of microRNAs: biology, functions, therapeutics, and analysis methods. J Cell Physiol. 2019;234(5):5451–5465.
   PubMed Web of Science ®Google Scholar
• Chen L, Heikkinen L, Wang C, et al. Trends in the development of miRNA bioinformatics tools. Brief Bioinform. 2019;20(1836–1852):1836–1852.
   PubMedGoogle Scholar
• Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer. 2006;6:259–269.
   PubMed Web of Science ®Google Scholar
• Rupaimoole R, Slack FJ. MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat Rev Drug Discov. 2017;16(3):203–222.
   PubMed Web of Science ®Google Scholar
• Zhu K, Ding H, Wang W, et al. Tumor-suppressive miR-218-5p inhibits cancer cell proliferation and migration via EGFR in non-small cell lung cancer. Oncotarget. 2016;7(19):28075–28085.
   PubMedGoogle Scholar
• Peng Z, Pan L, Niu Z, et al. Identification of microRNAs as potential biomarkers for lung adenocarcinoma using integrating genomics analysis. Oncotarget. 2017;8:64143–64156.
   PubMedGoogle Scholar
• Yang Q, Li J, Hu Y, et al. MiR-218-5p suppresses the killing effect of natural killer cell to lung adenocarcinoma by targeting SHMT1. Yonsei Med J. 2019;60:500.
   PubMed Web of Science ®Google Scholar
• Zhu J, Wang M, Hu D. Development of an autophagy-related gene prognostic signature in lung adenocarcinoma and lung squamous cell carcinoma. PeerJ. 2020;8(e8288):e8288.
   PubMedGoogle Scholar
• Tanaka T, Kutomi G, Kajiwara T, et al. Cancer-associated oxidoreductase ERO1-α promotes immune escape through up-regulation of PD-L1 in human breast cancer. Oncotarget. 2017;8:24706–24718.
   PubMedGoogle Scholar
• Kutomi G, Tamura Y, Tanaka T, et al. Human endoplasmic reticulum oxidoreductin 1-α is a novel predictor for poor prognosis of breast cancer. Cancer Sci. 2013;104:1091–1096.
   PubMed Web of Science ®Google Scholar
• Seol SY, Kim C, Lim JY, et al. Overexpression of endoplasmic reticulum oxidoreductin 1-α (ERO1L) is associated with poor prognosis of gastric cancer. Cancer Res Treat. 2016;48:1196–1209.
   PubMed Web of Science ®Google Scholar
• Zhang J, Yang, J., Lin, C., Liu, W., Huo, Y., Yang, M., Jiang, S. H., Sun, Y., et al. Endoplasmic Reticulum stress-dependent expression of ERO1L promotes aerobic glycolysis in Pancreatic Cancer. Theranostics. 2020;10:8400–8414. DOI:10.7150/thno.45124
   Web of Science ®Google Scholar
• Zhou J, Liu B, Li Z, et al. Proteomic analyses identify differentially expressed proteins and pathways between low-risk and high-risk subtypes of early-stage lung adenocarcinoma and their prognostic impacts. Mol Cell Proteomics. 2021;20:100015.
   PubMed Web of Science ®Google Scholar
• Yang S, Yang C, Yu F, et al. Endoplasmic reticulum resident oxidase ERO1-Lalpha promotes hepatocellular carcinoma metastasis and angiogenesis through the S1PR1/STAT3/VEGF-A pathway. Cell Death Dis. 2018;9(1105). DOI:10.1038/s41419-018-1134-4
   Google Scholar
• Luo W, He D, Zhang J, et al. Knockdown of PPARδ induces vegfa-mediated angiogenesis via interaction with ERO1A in human colorectal cancer. Front Oncol. 2021;11(713892). DOI:10.3389/fonc.2021.713892
   Google Scholar
• Zilli F, Marques Ramos P, Auf der Maur P, et al. The NFIB-ERO1A axis promotes breast cancer metastatic colonization of disseminated tumour cells. EMBO Mol Med. 2021;13(e13162). DOI:10.15252/emmm.202013162
   PubMedGoogle Scholar
• Gan TQ, Chen, W. J., Qin, H., Huang, S. N., Yang, L. H., Fang, Y. Y., Pan., et al. Clinical value and prospective pathway signaling of microRNA-375 in lung adenocarcinoma: a study based on the Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO) and bioinformatics analysis. Med Sci Monit. 2017;23:2453–2464.
   PubMed Web of Science ®Google Scholar
• Jiang N, Zou C, Zhu Y, et al. HIF-1ɑ-regulated miR-1275 maintains stem cell-like phenotypes and promotes the progression of LUAD by simultaneously activating Wnt/β-catenin and Notch signaling. Theranostics. 2020;10:2553–2570.
   PubMed Web of Science ®Google Scholar
• Huang D, Li C. circ-ACACA promotes proliferation, invasion, migration and glycolysis of cervical cancer cells by targeting the miR-582-5p/ERO1A signaling axis. Oncol Lett. 2021;22(795). DOI:10.3892/ol.2021.13056
   Google Scholar
• Wang G, Han J, Wang G, et al. ERO1α mediates endoplasmic reticulum stress-induced apoptosis via microRNA-101/EZH2 axis in colon cancer RKO and HT-29 cells. Hum Cell. 2021;34:932–944.
   PubMed Web of Science ®Google Scholar
• Yang J, Xu Y, Huo Y, et al. ERO1L promotes hepatic metastasis through activating epithelial-mesenchymal transition (EMT) in pancreatic cancer. J Immunol Res. 2021;2021(5553425):1–10.
   Google Scholar
• Zeng F, Wang Q, Wang S, et al. Linc00173 promotes chemoresistance and progression of small cell lung cancer by sponging miR-218 to regulate Etk expression. Oncogene. 2020;39:293–307.
   PubMed Web of Science ®Google Scholar
• Lei Y, Zang, R., Lu, Z., Zhang, G., Huang, J., Liu, C., Wang, Z., Mao, S., Che, Y., Wang., et al. ERO1L promotes IL6/sIL6R signaling and regulates MUC16 expression to promote CA125 secretion and the metastasis of lung cancer cells. Cell Death Dis. 2020;11(853). DOI:10.1038/s41419-020-03067-8
   Google Scholar
• Shi X, Wu J, Liu Y, et al. ERO1L promotes NSCLC development by modulating cell cycle-related molecules. Cell Biol Int. 2020;44:2473–2484.
   PubMed Web of Science ®Google Scholar
• Liu LP, Lu, L., Zhao, Q. Q., Kou, Q. J., Jiang, Z. Z., Gui, R., Luo, Y. W., et al. Identification and validation of the pyroptosis-related molecular subtypes of lung adenocarcinoma by bioinformatics and machine learning. Front Cell Dev Biol. 2021;9(756340). DOI:10.3389/fcell.2021.756340
   Google Scholar
• Arbour KC, Riely GJ. Systemic therapy for locally advanced and metastatic non-small cell lung cancer: a review. JAMA. 2019;322:764–774.
   PubMed Web of Science ®Google Scholar
• Nelson KM, Weiss GJ. MicroRNAs and cancer: past, present, and potential future. Mol Cancer Ther. 2008;7:3655–3660.
   PubMed Web of Science ®Google Scholar
• Wang B, Wang D, Yan T, et al. MiR-138-5p promotes TNF-alpha-induced apoptosis in human intervertebral disc degeneration by targeting SIRT1 through PTEN/PI3K/Akt signaling. Exp Cell Res. 2016;345:199–205.
   PubMed Web of Science ®Google Scholar
• Mao Y, Wu S, Zhao R, et al. MiR-205 promotes proliferation, migration and invasion of nasopharyngeal carcinoma cells by activation of AKT signalling. J Int Med Res. 2016;44:231–240.
   PubMed Web of Science ®Google Scholar
• Li S, Zeng A, Hu Q, et al. miR-423-5p contributes to a malignant phenotype and temozolomide chemoresistance in glioblastomas. Neuro Oncol. 2017;19:55–65.
   PubMed Web of Science ®Google Scholar
• Shergalis AG, Hu S, Bankhead A 3rd, et al. Role of the ERO1-PDI interaction in oxidative protein folding and disease. Pharmacol Ther. 2020;210(107525). DOI:10.1016/j.pharmthera.2020.107525
   PubMedGoogle Scholar
• Araki K, Nagata K. Functional in vitro analysis of the ERO1 protein and protein-disulfide isomerase pathway. J Biol Chem. 2011;286:32705–32712.
   PubMed Web of Science ®Google Scholar
• Cabibbo A, Pagani M, Fabbri M, et al. ERO1-L, a human protein that favors disulfide bond formation in the endoplasmic reticulum. J Biol Chem. 2000;275:4827–4833.
   PubMed Web of Science ®Google Scholar
• Yan W, Wang X, Liu T, et al. Expression of endoplasmic reticulum oxidoreductase 1-α in cholangiocarcinoma tissues and its effects on the proliferation and migration of cholangiocarcinoma cells. Cancer Manag Res. 2019;11:6727–6739.
   PubMed Web of Science ®Google Scholar
• Popper HH. Progression and metastasis of lung cancer. Cancer Metastasis Rev. 2016;35:75–91.
   PubMed Web of Science ®Google Scholar
• Frezzetti D, Gallo M, Maiello MR, et al. VEGF as a potential target in lung cancer. Expert Opin Ther Targets. 2017;21:959–966.
   PubMed Web of Science ®Google Scholar
• Shepherd FA. Angiogenesis inhibitors in the treatment of lung cancer. Lung Cancer. 2001;34(Suppl 3):S81–89.
   PubMedGoogle Scholar
• Sun LL, Li WD, Lei FR, et al. The regulatory role of micro RNA s in angiogenesis-related diseases. J Cell Mol Med. 2018;22:4568–4587.
   PubMed Web of Science ®Google Scholar
• Wang W, Hong G, Wang S, et al. Tumor-derived exosomal miRNA-141 promote angiogenesis and malignant progression of lung cancer by targeting growth arrest-specific homeobox gene (GAX). Bioengineered. 2021;12:821–831. DOI:10.1080/21655979.2021.1886771
   Web of Science ®Google Scholar
• Liu B, Peng XC, Zheng XL, et al. MiR-126 restoration down-regulate VEGF and inhibit the growth of lung cancer cell lines in vitro and in vivo. Lung Cancer. 2009;66:169–175.
   PubMed Web of Science ®Google Scholar